Oncology Institute Shares Outstanding vs. Market Capitalization
| TOI Stock | USD 0.17 0.02 13.33% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.22 | 0.1837 |
|
|
For Oncology Institute profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Oncology Institute to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Oncology Institute utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Oncology Institute's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Oncology Institute over time as well as its relative position and ranking within its peers.
Oncology |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share 4.873 | Quarterly Revenue Growth 0.229 | Return On Assets (0.19) | Return On Equity (1.26) |
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oncology Institute Market Capitalization vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Oncology Institute's current stock value. Our valuation model uses many indicators to compare Oncology Institute value to that of its competitors to determine the firm's financial worth. Oncology Institute is rated below average in shares outstanding category among its peers. It is rated below average in market capitalization category among its peers creating about 0.15 of Market Capitalization per Shares Outstanding. The ratio of Shares Outstanding to Market Capitalization for Oncology Institute is roughly 6.60 . As of now, Oncology Institute's Market Cap is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oncology Institute's earnings, one of the primary drivers of an investment's value.Oncology Market Capitalization vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Oncology Institute |
| = | 75.56 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Oncology Institute |
| = | 11.45 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Oncology Market Capitalization vs Competition
Oncology Institute is rated below average in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 78.63 Billion. Oncology Institute adds roughly 11.45 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Oncology Institute Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Oncology Institute, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Oncology Institute will eventually generate negative long term returns. The profitability progress is the general direction of Oncology Institute's change in net profit over the period of time. It can combine multiple indicators of Oncology Institute, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -7.3 M | -6.9 M | |
| Operating Income | -77 M | -73.2 M | |
| Net Loss | -75.3 M | -71.6 M | |
| Income Before Tax | -83.1 M | -78.9 M | |
| Total Other Income Expense Net | -6.1 M | -5.8 M | |
| Net Income Applicable To Common Shares | 61.2 K | 64.3 K | |
| Net Loss | -83.1 M | -78.9 M | |
| Income Tax Expense | -36 K | -34.2 K | |
| Non Operating Income Net Other | 98.8 M | 103.8 M | |
| Change To Netincome | -42.5 M | -40.4 M | |
| Net Loss | (1.13) | (1.07) | |
| Income Quality | 0.44 | 0.46 | |
| Net Income Per E B T | 1.00 | 1.12 |
Oncology Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Oncology Institute. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Oncology Institute position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Oncology Institute's important profitability drivers and their relationship over time.
Use Oncology Institute in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oncology Institute position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncology Institute will appreciate offsetting losses from the drop in the long position's value.Oncology Institute Pair Trading
Oncology Institute Pair Trading Analysis
The ability to find closely correlated positions to Oncology Institute could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oncology Institute when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oncology Institute - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oncology Institute to buy it.
The correlation of Oncology Institute is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oncology Institute moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oncology Institute moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oncology Institute can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Oncology Institute position
In addition to having Oncology Institute in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Convertibles Funds Thematic Idea Now
Convertibles Funds
Funds or Etfs that invest in debt that is expected to be converted into a predetermined amount of the company equity at some future date. The Convertibles Funds theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Convertibles Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
To fully project Oncology Institute's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Oncology Institute at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Oncology Institute's income statement, its balance sheet, and the statement of cash flows.